Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
Supporting Files
Public Domain
File Language:
English
Details
-
Alternative Title:Emerg Infect Dis
-
Description:We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited.
-
Subjects:
-
Pubmed ID:28758889
-
Pubmed Central ID:PMC5621552
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:23
-
Issue:10
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha256:301a76b26a3e6564c329d3e918d9c2bb9e6abbed78597649108805b58db745ce
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
Emerging Infectious Diseases